Latvija -
latviešu -
Zāļu valsts aģentūra
bisoprolol zentiva 10 mg tabletes
zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 10 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
bisoprolol zentiva 1,25 mg tabletes
zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 1,25 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
bisoprolol zentiva 5 mg tabletes
zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 5 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
bisoprolol vitabalans 10 mg tabletes
vitabalans oy, finland - bisoprolola hemifumarāts - tablete - 10 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
bisoprolol vitabalans 5 mg tabletes
vitabalans oy, finland - bisoprolola hemifumarāts - tablete - 5 mg
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.